TABLE 2

Studies in left ventricular tissues

Redistribution Study (Fig. 1) PTX Study (Fig. 2)
Number of patients 11 2
Mean Age ± S.D. (years) 56 ± 2 (34—65) 63—52
Gender 10 M, 1 F 2 M
LVEF (%) ± S.D. 20 ± 2 20 —20
Indication 6 DCM/5 ICM 2 ICM
β-blocker treatment 4/11 1/2
Aspirin treatment 0/11 0/2
Zinterol effect on cPLA2 activity 6, activation/ 5, inhibition 1, activation/1, inhibition
  • M, male; F, female; DCM dilated cardiomyopathy; ICM, ischemic cardiomyopathy; LVEF, left ventricular ejection fraction.